Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway.
- Resource Type
- Article
- Source
- FEBS Open Bio; Aug2021, Vol. 11 Issue 8, p2256-2265, 10p
- Subject
DRUG resistance MULTIDRUG resistance DOXORUBICIN SMALL cell lung cancer INFLAMMATORY mediators ENDOTHELIAL growth factors RESVERATROL - Language
- ISSN
- 22115463